Found: 131
Select item for more details and to access through your institution.
A Rare and Treatable Cause of Medullar Claudication: Spinal Dural Arteriovenous Fistula.
- Published in:
- Ochsner Journal, 2019, v. 19, n. 4, p. 397, doi. 10.31486/toj.18.0026
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Imaging spectrum of Bing-Neel syndrome: how can a radiologist recognise this rare neurological complication of Waldenström's macroglobulinemia?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study.
- Published in:
- European Radiology, 2014, v. 24, n. 12, p. 3069, doi. 10.1007/s00330-014-3342-3
- By:
- Publication type:
- Article
Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis.
- Published in:
- Digital Health, 2023, p. 1, doi. 10.1177/20552076231173531
- By:
- Publication type:
- Article
Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis.
- Published in:
- Digital Health, 2023, v. 9, p. 1, doi. 10.1177/20552076231173531
- By:
- Publication type:
- Article
Optical coherence tomography: a window to the optic nerve in clinically isolated syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11893, doi. 10.3390/ijms231911893
- By:
- Publication type:
- Article
Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2024, v. 10, n. 1, p. 1, doi. 10.1177/20552173241233952
- By:
- Publication type:
- Article
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.991291
- By:
- Publication type:
- Article
Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.763433
- By:
- Publication type:
- Article
Multiple sclerosis and depression: influence of interferon β therapy.
- Published in:
- Multiple Sclerosis (13524585), 2003, v. 9, n. 3, p. 284, doi. 10.1191/1352458503ms915oa
- By:
- Publication type:
- Article
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211058298
- By:
- Publication type:
- Article
Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Double‐blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate‐to‐severe relapses of multiple sclerosis.
- Published in:
- Journal of Clinical Apheresis, 2020, v. 35, n. 4, p. 281, doi. 10.1002/jca.21788
- By:
- Publication type:
- Article
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1591, doi. 10.1177/13524585221083194
- By:
- Publication type:
- Article
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1526, doi. 10.1177/13524585221076717
- By:
- Publication type:
- Article
Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1219, doi. 10.1177/13524585211049392
- By:
- Publication type:
- Article
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1155, doi. 10.1177/13524585211049737
- By:
- Publication type:
- Article
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 842, doi. 10.1177/13524585211061335
- By:
- Publication type:
- Article
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 4, p. 608, doi. 10.1177/13524585211032803
- By:
- Publication type:
- Article
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 10, p. 1564, doi. 10.1177/1352458520971819
- By:
- Publication type:
- Article
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 10, p. 1556, doi. 10.1177/1352458520969145
- By:
- Publication type:
- Article
Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 5, p. 729, doi. 10.1177/1352458520936239
- By:
- Publication type:
- Article
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1866, doi. 10.1177/1352458519888610
- By:
- Publication type:
- Article
Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1719, doi. 10.1177/1352458519881759
- By:
- Publication type:
- Article
Optic nerve double inversion recovery hypersignal in patients with clinically isolated syndrome is associated with asymptomatic gadolinium-enhanced lesion.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1888, doi. 10.1177/1352458518815797
- By:
- Publication type:
- Article
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 6, p. 819, doi. 10.1177/1352458518771875
- By:
- Publication type:
- Article
Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 14, p. 1902, doi. 10.1177/1352458517750765
- By:
- Publication type:
- Article
Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 12, p. 1594, doi. 10.1177/1352458517727603
- By:
- Publication type:
- Article
Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 4, p. 604, doi. 10.1177/1352458516657441
- By:
- Publication type:
- Article
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 11, p. 1386, doi. 10.1177/1352458516643600
- By:
- Publication type:
- Article
The patient’s perspective: How to create awareness for improving access to care and treatment of MS patients?
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, p. 9, doi. 10.1177/1352458516650742
- By:
- Publication type:
- Article
Introduction: Do we need multi-stakeholder colloquia in MS?
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, p. 4, doi. 10.1177/1352458516650740
- By:
- Publication type:
- Article
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, p. 18, doi. 10.1177/1352458516650739
- By:
- Publication type:
- Article
Conclusions: Calls to action for improving the life of MS patients and their families.
- Published in:
- 2016
- By:
- Publication type:
- Proceeding
A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1781, doi. 10.1177/1352458515578888
- By:
- Publication type:
- Article
Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 8, p. 1135, doi. 10.1177/1352458513515081
- By:
- Publication type:
- Article
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 7, p. 822, doi. 10.1177/1352458513505353
- By:
- Publication type:
- Article
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 6, p. 705, doi. 10.1177/1352458513507821
- By:
- Publication type:
- Article
Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.676585
- By:
- Publication type:
- Article
An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132142
- By:
- Publication type:
- Article
Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090509
- By:
- Publication type:
- Article
Bent spine syndrome as the initial symptom of late-onset Pompe disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rituximab in refractory and non-refractory myasthenia: A retrospective multicenter study.
- Published in:
- Muscle & Nerve, 2012, v. 46, n. 5, p. 687, doi. 10.1002/mus.23412
- By:
- Publication type:
- Article
Recurrent multiple cranial nerve palsy and anti-GD1a antibodies.
- Published in:
- Muscle & Nerve, 2011, v. 43, n. 3, p. 447, doi. 10.1002/mus.21958
- By:
- Publication type:
- Article
Phrenic nerve palsy as a feature of chronic inflammatory demyelinating polyradiculoneuropathy.
- Published in:
- Muscle & Nerve, 2003, v. 27, n. 4, p. 497, doi. 10.1002/mus.10361
- By:
- Publication type:
- Article
Cardiac repolarization abnormalities in multiple sclerosis: spinal cord MRI correlates.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Social participation in patients with multiple sclerosis: correlations between disability and economic burden.
- Published in:
- BMC Neurology, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2377-14-115
- By:
- Publication type:
- Article